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Abstract: 
Rapid advances in biotechnology have created new demands for tests of mouse behaviour having both high 
reliability and high throughput for mass screening. This paper discusses several statistical and psychological 
factors pertinent to replication of results in different laboratories, and it considers the question of which inbred 
strains are best for test standardization. In this context, the problem of absent corpus callosum in the 129 strains 
is addressed with data from a recent study of six diverse tests of behaviour, and it is shown that effects of absent 
corpus callosum are usually nonsignificant and/or very small. Whether any 129 substrain is to be included in the 
list of standard strains depends on the goal of the standardization — collecting diverse phenotypic data on most 
available strains by a few expert investigators (the gold standard) or refining behavioural tests in order to 
establish a normal range of behaviour that can be used to judge a wider range of strains or even an individual 
mouse.  
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Article: 
1. Introduction 
Current interest in the question of standardizing tests of mouse behaviour is inspired by a number of recent 
developments. Extensive reviews of numerous tests of mouse behavior [9,10] have helped to make many of 
these techniques accessible to a wide variety of scientists, while conferences such as the meeting on 
‘Behavioural Phenotyping of Mouse Mutants’ held at the University of Köln in February of 2000 have also 
drawn attention to these issues. Funding from the National Institutes of Health in the USA directed specifically 
to testing behaviours of inbred mouse strains and mutants has encouraged many investigators to undertake 
research in this area. 
 
Rapid advances in biotechnology are exerting pressure on neurobehavioural genetics to provide better tools for 
assessing behaviour [36,38]. Lederhendler and Schulkin [20] recently noted: ‘As new genes are identified, 
scientific interest turns to their functions. To determine the function of genes, particularly how they contribute 
to behavior, molecular biologists need, and have been vigorously requesting, reliable phenotypes’. Large scale 
genetic screening programs to detect effects of induced mutations on behaviour are beginning to yield reams of 
data [4,27]. At the same time, there is discussion as to whether the screening programs might benefit from more 
extensive testing with standard in-bred strains [32] or a richer array of behavioural tests [20]. 
 
Two features of a useful behavioural test are paramount when our colleagues ask us for better measuring 
instruments. First, they want more efficient and sensitive tests suitable for high-throughput testing of 
hundreds or thousands of animals. Second, they want tests that are likely to yield similar results in the hands of 
different investigators. Both of these features may be enhanced by appropriate standardization of the tests. Each 
kind of test entails numerous features such as apparatus dimensions and materials, lighting conditions, trial 
duration, handling by the experimenter, and so forth. An informed choice of parameters ought to yield a more 
reliable and therefore more sensitive test. Use of a standard set of parameters in different labs should also 
enhance the repeatability of test results. 
 
Whenever one seeks to standardize any test, a crucial factor is the choice of genetic strains on which to base the 
standard. It is not necessarily true that more strains in the standard sample result in better test standardization, 
because a more diverse sample is more likely to include strains with major neurological abnormalities. This 
issue, to be discussed in detail in this paper with regard to absence of the corpus callosum, brings into focus two 
goals of standardization. One might want to establish norms for behavioural variation, such that a strain or an 
individual animal later found outside the normal range would be considered aberrant, as is done in mutagenesis 
screening. Alternatively, one might want to establish benchmark data for a wide variety of strains in order to 
allow many other laboratories to evaluate their environments and procedures against genetically well defined 
standards. Both approaches would benefit from research explicitly designed to identify behavioural tests of high 
reliability, but they may differ in the attitude towards mouse strains that pre-form very poorly. If a strain 
afflicted by absent corpus callosum does poorly, we would like to know whether this indicates something 
fundamentally wrong with the mouse or instead reveals a flaw in the test itself that may be overcome by a better 
apparatus design or test procedure. 
 
Some colleagues have expressed doubts about the wisdom of standardizing tests. Würbel [42], for example, 
disputes a ‘standardization fallacy’, the mistaken belief that standardization will eliminate individual variability 
in behaviour. There is no need to fret about this possibility, however. Strenuous attempts to render the 
laboratory environment perfectly uniform in order to expunge individual differences among genetically 
identical, inbred mice, have met with failure even for anatomical and physiological phenotypes [13]. The vast 
literature on mouse behaviour genetics accumulated over the past 40 years provides numerous examples of 
substantial within-strain variance in the confines of a single laboratory. If uniformity cannot be achieved within 
a single lab, there is no way that any kind of standardization will yield uniformity of behaviour across the entire 
field.  
 
2. Replicability of test results — statistical aspects 
Perhaps the strongest impetus towards standardization is the vexatious occurrence of divergent results when 
different laboratories work with the same or very similar genetic material. For example, three recent papers in 
Nature Genetics reported conflicting results concerning effects of corticotropin-releasing hormone (Crh) and 
one of its receptors (Crhr2) on mouse anxiety [1,7,18]. There are two potential sources of failures to replicate 
results across labs — statistical sampling error and systematic differences in the conditions of experimentation. 
 
Sampling error arises from differences among individuals in a group. When these differences are substantial, as 
almost always happens, then the specific set of individuals chosen for testing may have a sample mean score 
that deviates considerably from the population mean, and two samples drawn from the same population will 
often have markedly different means. Usually we seek to minimize this problem by studying reason-ably large 
samples and conducting statistical tests to persuade ourselves and our colleagues that the observed effects are 
real. A typical procedure is to compare controls and mutants with a test of ‘significance’ at the α = 0.05 level. If 
the apparent probability of obtaining a particular magnitude of difference between group means is less than 
0.05, then the genetic effect is said to be statistically significant. What this jargon means is that the probability 
of such a large difference occurring because of sampling error is so low that we infer the difference must not 
have arisen merely from chance. This procedure is a null hypothesis test, where the null is that there is no 
genuine genetic effect. When the null is true, a Type I error occurs if we reject the null hypothesis. The 
experimenter chooses a criterion for Type I error, symbolized a, that makes such an error relatively rare. 
 
Although great attention is often devoted to the appropriate level of Type I error in genetic research [19], this 
issue has little or nothing to do with test replicability. For one thing, the level of Type I error is insensitive to 
sample size; if there is truly no genetic effect, the probability of committing a Type I error is the same for paltry 
and huge samples. For another, replicability is a concern when there is a real effect to be detected, in which case 
the null hypothesis is a straw man. If there is a real effect, then the more plausible kind of error is Type II error, 
the failure to detect a real effect, which occurs with probability β. The level of Type II error is highly sensitive 
to sample size, being much lower for larger samples. 
 
For a single study in one lab, the probability of correctly rejecting the null hypothesis of no genetic effect is 1 − 
β, also known as the statistical power of the test. It is desirable that power be at least 80%, and a good argument 
can be made for 95% because this will make β = α = 0.05. The probability that two independent labs replicate or 
obtain evidence of the same genetic effect is simply (1 − β)
2
, and when each lab uses 1 − β = 0.8, they should 
replicate a real effect on 64% of their tests. Only when power is 95% or more will probability of replication be 
90% or more. 
 
It is essential to address the question of statistical power during the design phase of the study, before the data 
are collected [37]. There are two crucial determinants of power — the true effect size and sample size. Effect 
size when comparing two groups can be ex-pressed as the coefficient δ, which indicates the number of standard 
deviations by which true group means differ [37]. Often it is possible to make a plausible estimate of the likely 
effect size by examining the sample means and standard deviations from a previous experiment. As shown in 
Fig. 1, the dispersion of sample effect sizes will tend to be quite wide unless sample sizes are large. For a small 
effect of δ = 0.5, typical of quantitative trait locus (QTL) effects, there should be more than 30 animals per 
group to ensure that the sample effect size exceeds 0 and considerably more to ensure that the group difference 
is statistically significant. For a large effect of δ = 1.0 standard deviation, on the other hand, samples from 20 to 
30 mice per group should usually yield significant group differences. For even larger effects of δ > 2.0 standard 
deviations, typical of those sought in mutagenesis screening studies [27], probability of replication should 
generally be very high for statistical reasons. 
 
If more than one lab plans to examine the same genetic effect, it may be wise for them to use a more stringent 
criterion for Type I (α) error, because a false positive finding is more likely when many research groups test the 
same null hypothesis [37]. Using a smaller value of α will reduce the statistical power, however. The same 
difficulty confronts researchers when they conduct numerous null hypothesis tests within a single study, as we 
did in our comparison of the three labs [8]. The crucial consideration here is whether the null hypothesis is 
credible in the first place. Later in this paper, we compare brain sizes for mouse strains already known to differ 
substantially in brain size [25], and there is no good reason to deflate our α level when we are merely verifying 
established knowledge. 
 
 
 
 
3. Replicability and the three components of standardization 
If genetic and environmental effects on behaviour were perfectly additive, the same pattern of results of a 
genetic experiment should occur, even though environ-mental conditions in one lab lead to generally higher 
scores than in another lab. Thanks to the ubiquitous nature of gene –environment interaction, however, two labs 
may both employ large samples and reliable tests, yet fail to obtain the same results of a genetic experiment 
because the manifestation of genetic differences depends on the specific environment. Interaction is commonly 
observed in studies designed to detect it [6], and interaction is to be expected, given current knowledge about 
how genes function as parts of integrated systems [14,31]. In the presence of numerous factors leading to 
interaction, the only way to ensure similar outcomes of genetic experiments in different laboratories is to 
employ very similar, standardized conditions. If this goal is to be pursued seriously, three components of the 
process need to be standardized: the test situation itself, the laboratory environment prior to testing, and the 
genetic composition of the animal population. 
 
The test situation includes the physical conformation of the apparatus and stimulus parameters and well as the 
test protocol that specifies in great detail how the animals are to be tested. The laboratory environment includes 
all features of the animal’s surroundings that impinge on it from conception until just prior to testing. It is 
known that many aspects of a simple test such as the elevated plus maze can influence results [17,26], and 
abundant data also demonstrate the important of diverse aspects of the lab environment [2,12,43]. In almost all 
instances when conditions are compared across laboratories, both the test situations and the lab environments 
are found to vary along many dimensions, and it is therefore impossible to know why two labs may fail to 
obtain the same results. 
 
The study of Crabbe, Wahlsten and Dudek [8] addressed this problem by rigorously standardizing the details of 
the test apparatus and testing protocols for six commonly used behavioural tests and then conducting the tests 
simultaneously in three different laboratories using identical genetic groups. Although results were very similar 
for certain tests such as ethanol preference in a two-bottle test, large and significant strain by lab interactions 
were observed for several tests, including plus maze and cocaine activation. The interactions must have arisen 
from differences in the laboratory environments. Many aspects of the lab environment, such as the light–dark 
cycle and methods of handling, had been equated, but several apparently important factors that had not been 
equated evidently had strongly strain-specific effects. 
 
 
 
The experience of the Crabbe et al. [8] study suggests that comprehensive standardization of both the test 
situation and the lab environment is not feasible. As argued elsewhere [38], a more attainable goal is to establish 
a set of standard tests that can serve as a benchmark or baseline for comparison across labs. Any lab that wishes 
to do so could then run the benchmark tests and compare results with their own local variants. This approach 
would not require each lab to adopt a single, world-wide standard, yet it would make available a standard that 
would aid interpretation of differences between labs. How such a benchmark or consensus version of a test 
might be achieved is a difficult challenge that has not yet been overcome. 
 
4. Choosing standard strains 
Any attempt to standardize a behavioural test or establish a benchmark must pay close attention to the 
population of animals on which the standard is to be based. The finest plastic and steel device tested in the 
cleanest and most humane animal facility will be of little advantage if an unwise choice of animal subjects is 
made. Inbred strains of mice are ideal material for standardization of behavioural tests because each strain is 
genetically uniform and relatively stable over a period of time. The genetic material was standardized decades 
ago, including breeding regimens and nomenclature, and dozens of strains are readily available from 
commercial breeders. Thus, the major question is how many and which strains should be used as the standard. 
 
Paigen and Eppig [24] have recently proposed a short list of nine commonly used inbred strains that can serve 
as subjects for collecting standard phenotype data to be entered into the Mouse Phenome Database 
(http://aretha.jax.org/pub-cgi/phenome), along with an expanded list of more than 20 additional strains worthy 
of testing to detect diversity of behavioural phenotypes. These lists were the product of discussions among 36 
mouse specialists held at the Jackson Laboratories on May 9–10, 1999. In Table 1, salient characteristics of the 
short-listed strains are noted. 
 
It makes a great deal of sense to standardize a behavioural test with strains of mice that lack any major 
neurological abnormality. Then data on those strains can be used as a basis for judging when some other animal 
has a noteworthy deficit. Here we face an almost insurmountable challenge because so many of the common 
inbred strains possess one or more genetic defects that might influence behavioural test scores. Not one of the 
strains listed in Table 1 can be regarded as a standard of normality; each has some kind of noteworthy defect. 
Albinism itself has widespread physiological and behavioural consequences [11], and retinal degeneration 
eliminates all rods and then all cones in the retina, leaving greatly reduced visual function [16]. Despite these 
obvious shortcomings, the list of standard inbred strains has appeal because a minority of strains possesses any 
one defect, and comparisons across strains can yield important clues about the kinds of defects that may be most 
relevant for a particular behaviour. This pattern will be most readily interpreted for defects when at least two 
strains are afflicted, because one would expect both of them to show extreme scores in the same predicted 
direction. On the other hand, if only one strain has a particular defect and it shows an extreme score, a claim 
that the defect was the cause of the deviant behaviour is little more than a hunch, and further testing will 
certainly be needed to substantiate the relation. 
 
Establishing a genetic correlation between an anatomical defect of brain development and variation in mouse 
behaviour is best done with a large number of inbred strains. A short list of strains as in Table 1 may yield data 
suggesting or hinting that retinal degeneration is a problem, for example, but far more evidence will be needed 
to make the case for a genuine, causal connection. There is one situation, however, where a possible 
neurological cause may be readily evaluated, and we would like to describe an instance in some detail. This 
method relies on non-genetic phenotypic variation within an inbred strain rather than differences among strains. 
It is especially important because it involves 129 strain mice that are most commonly employed for producing 
genetic knockouts. 
 
5. The problem of absent corpus callosum in strain 129 mice 
One of the most dramatic neurological defects seen in any of the strains in Table 1 is absence of the corpus 
callosum (CC), a major axon pathway that normally interconnects the cerebral hemispheres and provides rapid 
transmission of information between the two sides of the cortex. The defect occurs at a relatively low frequency 
of less than 10% in the BALB/cByJ strain [41] but it afflicts more than 30% of the mice in many 129 strains. 
Somewhat surprisingly, the lack of a CC has no influence on mouse paw preference [5], but it does interfere 
with motor coordination on challenging tasks where speed of performance is crucial [28] Absent CC arises from 
recessive genetic defects at more than one locus [21,22,39], and the expression of the defect caused by certain 
targeted mutations depends on the genetic background [23]. 
 
Given the severe anatomical abnormality seen in the 129 strains, perhaps this strain should not be included in 
the short list of standard strains. Because of its common use as a source of embryonic stem cells for creating 
knockouts, however, there are compelling reasons to include it, at least for purposes of comparison with other 
strains. It is not clear which of the many substrains to include because of uncertainty about ancestries and 
evident genetic contamination in certain substrains [30,33], but the problem of absent CC is present in all 
substrains we have examined to date. The question that needs to be addressed is therefore whether absent CC in 
the 129 strains is likely to have significant impact on a wide range of behavioural tests. 
 
If absent CC occurred in every mouse in a 129 strain, it would be necessary to study F2 hybrid crosses or 
recombinant inbred strains in order to determine whether the inadequate performance of 129 on a behavioural 
test is causally related to absent CC or merely a spurious correlate of a curious anomaly. Fortunately, the defect 
shows ‘incomplete penetrance’, meaning that only a subset of genetically identical mice is afflicted. This 
interesting fact of forebrain development allows a convenient assessment of CC function within the strain. We 
would like to present new data from a recent study to illustrate this application. Details of the behavioural tests 
have been presented previously [8].  
 
5. 1. Animals 
Equal numbers of males and females of the inbred strains A/J, BALB/cByJ, C57BL/6J, DBA/2J, and the 
B6D2F1/J hybrid were obtained from the Jackson Lab-oratory, Bar Harbor, Maine, USA. The 129/SvEvTac 
strain was obtained from Taconic Farms. The 5HT1B knockout and its 129/Svter control strain [15] were 
generously provided by Dr Rene´ Hen at Columbia University, New York, USA. All mice were 11 weeks of 
age when testing began. Half of them had been bred in each laboratory from parents shipped about 3 months 
earlier, and half were shipped 5 weeks prior to testing. 
 
The breeding and then testing were done simultaneously under very similar conditions at three sites— the State 
University of New York in Albany, Oregon Health Sciences University in Portland, and the University of 
Alberta in Edmonton. Many of the environmental conditions were rigorously equated, but some aspects of the 
environments in the three labs could not be equated. 
 
5.2. Apparatus and testing protocols 
Identical test apparatus and testing protocols were employed at the three sites. These were adopted after a long 
series of discussions and negotiations conducted mainly via email among the three labs. The specific parameters 
were not necessarily chosen because they would be optimal; rather, some were chosen because they could be 
conveniently used at all three sites. Full details of the tests are provided in the web site for this study 
(http://www.albany.edu/psy/obssr). Briefly, each mouse received one test each day in the same order, consisting 
of open field activity on Monday, elevated plus maze on Tuesday, accelerating rotorod on Wednesday, visible 
platform water escape learning on Thursday, cocaine activation of open field activity on Friday, rest on 
Saturday, two-bottle drinking acclimation on Sunday, and then two-bottle ethanol preference testings for 4 days, 
followed by euthansia and collection of brains for histology. The study was conducted with two replications, 
each requiring 2 weeks of testing, and starting 1 week apart. Replication effects were generally absent or very 
small and are not presented here. Within a day, the order of testing the different strains, sexes, and treatment 
conditions was randomized; different random orders were used in the three labs and for the replications. 
 
Open field activity was assessed in a 15 min trial in the 40 × 40 × 30 cm high clear plastic Digiscan photo-cell 
beam apparatus made by AccuScan Inc. Testing was done in total darkness in order to equate lighting 
conditions in all three labs. 
 
Elevated plus mazes (5 × 25 cm black plastic arms with a 5 × 5 cm central area, 2.5 mm clear plastic rim 
on open arms, 15 cm clear plastic walls on enclosed arms; arms 50 cm above the floor) were manufactured in 
the University of Alberta shop and shipped to the other two sites. Mice received one trial of 5 min duration 
under about 100 Lux illumination, and behaviour was scored from video tape. 
 
Rotorod testing was administered on schedule to all mice according to a standard schedule, but a flaw in the 
surface of the rod at one site was so serious that many mice were able to grasp it tightly and remain on the rod 
without moving. This clever but inconsistent behaviour rendered the data uninterpretable, and further 
presentation of this task would not be edifying. 
 
Water escape tanks 70 cm in diameter and 25 cm deep were cast in polyethylene in Edmonton and shipped to 
the other sites, along with a 15 cm black mesh platform placed in the centre of the tank that extended 5 mm 
above the surface. Water was kept within one degree of 25 ºC. The mouse was started at the edge of the tank at 
one of four randomly chosen compass locations and allowed 40 s to find the central platform. It received eight 
trials in 1 day with a 30 s intertrial interval. 
 
Cocaine activation was assessed with a 15 min trial in the DigiScan apparatus immediately after an 
intraperitoneal injection of 20 mg/kg cocaine. 
 
Ethanol preference was assessed with 6% (v/v) ethanol in local tap water versus local tap water. One reading 
was taken each day, and the position of the ethanol and tap water tubes was reversed after 2 days. 
 
5.3. Histology 
High quality histological assessment of mouse brain can be a very labour intensive enterprise that is not 
compatible with high throughput phenotyping. Accordingly, we devised a much faster method for studying CC 
defects that is nevertheless valid for identifying mice with very small or totally absent CC. We did not perfuse 
the mouse with fixative; instead, after euthanasia, the fresh brain was carefully removed from the skull and then 
immersed in either 4% buffered paraformaldehyde or 10% buffered formalin (from 37% stock formaldehyde 
solution). We are grateful to Dr Pierre Roubertoux for suggesting this modification of our earlier method. 
Brains collected in Albany and Portland were shipped to Edmonton for further processing. After at least 2 
weeks in fixative, each brain was weighed to the nearest mg and then bisected along the midsagittal plane. The 
left half was stained en bloc with gold chloride using the method of Schmued [29] to reveal myelin. After 
fixation of the stain with 2% sodium thiosulfate, a video image of the surface of the brain was taken with the 
JAVA system from Jandel Scientific, and the cross-sectional areas of the corpus callosum, (CC), hippocampal 
commissure (HC), and anterior commissure (AC) were measured. The maxi-mum length of the CC was also 
recorded. 
 
5.4. Results—measures of brain 
Data were evaluated using a factorial analysis of variance (ANOVA) on eight genetic groups, two sexes, three 
sites, and two kinds of breeding (local or shipped), with four mice in each of the 96 groups and 281 degrees of 
freedom for the within-group variance. The sample size for this study was chosen to yield a high level of power 
(90%) for detecting a moderate strain by site interaction in which hypothetical rank orders of strains were 
invariant but the magnitude of strain differences varied across labs. Because the sample size required to detect 
an interaction is commonly greater than that needed to detect a main effect [35], power of tests of moderate 
main effects was consider-ably greater than 90%. While the strain by site interaction was assessed with 12 mice 
per group (two sexes × two shipping conditions × four mice), the sex main effect was assessed with about 190 
mice per sex. 
 
Given the small sample size within any one group, it was not possible to assess the normality of data and 
equality of variances on a group by group basis, but close inspection of the data indicated that most data were 
reasonably close to normally distributed and variances were not markedly heterogeneous for body size, brain 
size, or anterior commissure area. For the hippocampal commissure, there were a few extremely low scores in 
the three groups with 129 genes. The ANOVAs are summarized in Table 2 where only effects significant at α = 
0.01 or better are reported. Entries in the table are partial omega-squared values derived from the F ratio for 
each effect to express the percentage of variance attributable to the differences among group means if only that 
one factor is considered in the ANOVA. Strain differences were generally very large but a sex difference was 
seen only for body weight. There were no significant effects of breeding locally versus fresh shipping from the 
suppliers. Substantial differences among the three sites were seen for body and brain sizes as well as areas of 
the AC and HC. Because CC size was obviously not normally distributed (Fig. 2), effects were tested with 
ANOVA after removing mice with small CC (< 2 mm length), which tended to increase strain means for the 
three 129- derived groups and thereby reduce the apparent strain effect size. Brain size differences among sites 
were not a simple consequence of body size; average body sizes were largest in Portland (24.1 g) and smaller in 
Albany (22.9 g) and Edmonton (22.3 g), whereas average brain sizes were largest in Albany (0.490 g) but 
similar in Portland (0.466 g) and Edmonton (0.469 g). The site effect on anterior commissure size, on the other 
hand, was largely but not entirely accounted for by differences in overall brain size when multiple regression 
methods were used [3]. 
 
 
Origins of the body and brain size effects are not known for certain because the variation among lab 
environments was multifactorial. Mice drank local tap water and breathed local, fresh air. Although they all 
were fed Purina 5001 diet, this kind of diet can involve local differences in the specific sources of protein and 
other constituents of the diet [34]. The objective of the comparative study was not to equate lab environments. 
Rather, it was designed to determine whether the ubiquitous, largely unavoidable differences between 
laboratories would alter the pattern of genetic differences evident in test scores. For several behaviours, there 
was significant strain by site interaction [8], but for the features of brain presented here, no interaction was seen. 
 
Size of the CC can be expressed conveniently in terms of its total length at the midsagittal plane (Fig. 2). Apart 
from one BALB/cByJ mouse with a short CC, absent or very short CC was seen only in the 129 strains and the 
knockout. Frequency of absent or very small CC ranged from 30% in Edmonton to 42% in Albany, but the site 
difference was not significant (χ
2
 = 1. 3, df = 2, P > 0. 10). Most cases of defective CC involved total absence, 
but a wide range of phenotypic expression was apparent for all three 129 strain groups, and the 2 mm cutoff for 
abnormality was somewhat arbitrary [39]. 
 
5.5. Results—measures of behaviour 
Given the variability in CC size within a 129 strain, possible effects on behaviour can be addressed either by 
dichotomizing at the 2 mm criterion and conducting t-tests or computing non-parametric correlations between 
CC length and test scores. These analyses were done by pooling data for the three 129 groups, which did not 
differ significantly among themselves with respect to either the CC or most behavioural measures. 
This yielded one large 129 strain group with 139 mice, 52 of which clearly had abnormal CC (see Table 3). 
That sample size was adequate to detect a substantial effect size of δ = 0.7 with 90% power when α = 0.01. 
Using more liberal but conventional values of α = 0.05 and β = 0.2, n = 52 would be adequate to detect a small 
effect size of δ = 0.5. The t-tests on dichotomized data suggested only one possible effect of the CC defect-a 
reduction in percent time in the open arms of the plus maze. The Spearman correlations pointed to several other 
small correlations that were just beyond the critical value for significance at α = 0.01, but these were more 
difficult to interpret because the values were also influenced by mice whose CC sizes were definitely within the 
normal range of variation. Scatterplots of scores involved in three of the correlations with r > 0.2 are shown in 
Fig. 3. For open field activity (Fig. 3A), the result was influenced by one very active mouse with a long CC. For 
wall hugging (Fig. 3B), the spread of scores was similar throughout the range of CC values but there was a 
moderate concentration of values near 100% for mice with no CC. Percent time in the open arms of the plus 
maze (Fig. 3C) was at 100% for several mice with normal CC, and this extreme score invariably occurred for 
animals that entered an open arm at the start of the trial and remained immobile. Wall hugging scores near 
100% in the open field and open arm time near 100% in the plus maze almost always appeared in mice that 
were inactive. Hence, it would be hazardous to take these small correlations as a sign that absent CC increased 
anxiety. 
 
 
Although these data do not prove that the lack of a CC in 129 strain mice has no effect on behaviour, they 
certainly indicate that any effect must be quite small for these particular tests. When using these sample sizes, 
an observed effect size of about d = 0.2 yields a 95% confidence interval for the true effect size δ that ranges 
from − 0.16 to 0.56. While it may not be entirely safe to ignore the problem of absent CC when studying 
behaviours that are not believed to be closely related to interhemispheric transfer, the magnitude of the effect is 
not likely to be very large. Thus, if the research focuses on genetic effects that themselves are clearly 
substantial, it may be implausible to believe that the genetic effect is a mere artifact of absent CC in 129 strain 
mice. 
 
 
 
5.6. Results — effects of the serotonin 1B receptor knockout 
As a case in point, the same methods used to judge CC effects were then used to judge the knockout effect by 
comparing the 5HT1B − / − homozygotes with 129/Sv-ter controls. This analysis revealed two interesting 
effects. Brain weight of the knockouts averaged 491 mg versus 466 mg for the controls, a difference of d= 1.14 
standard deviations that was obviously significant (P = 0.000001). Among the many behavioural measures, only 
in the open field was a knockout effect apparent; the − / − homozygotes travelled further in 15 min (2965 versus 
2249 cm, d = 0.53, P = 0.02), and the − / − homozygotes exhibited a higher level of rearing (52.7 versus 28.1 
movements, d = 0.77, P= 0.001). For neither of these behavioural measures was there a difference within either 
genetic group between mice with normal and abnormal CC. 
 
5. 7. Conclusion about absent CC in strain 129 mice 
In many ways, 129 mice are not a good choice for standardization of any behavioural test because they often 
show extreme scores in comparison with other inbred strains and because of continuing uncertainty about the 
best substrain to use. These problems arise independently of the challenge of absent CC, which by itself makes 
them less than ideal as a standard for judging what is normal and abnormal behaviour. The 129 strain will 
nevertheless be found on most re-searchers’ short list of inbred strains for standard testing solely because they 
are now so widely used in neurobehavioural genetics to produce knockouts. In this context, it would be wise to 
check for effects of absent CC in most studies. Only when a fairly large base of information from several labs is 
available, one large enough to allow meta-analysis, can we with greater confidence assert that there is no 
problem because of absent CC. The anatomical defect looks severe to the human observer, whereas the t-tests of 
behavioural effects are often less worrisome. Rather than dismiss the problem of absent CC as unworthy of 
concern in a general sense, it would be more helpful to expand the investigations until we can state that certain 
behaviours are clearly affected by CC absence, whereas others show little or no effects. 
 
 
6. Different meanings of test standardization 
The problem of absent CC in strain 129 mice brings into focus two approaches to standardization. The first, 
exemplified by Paigen and Eppig [24], seeks to collect a wide range of phenotypic data on numerous inbred 
strains in order to create a database of strain characteristics, much as has already been done for allelic variants 
in different strains. According to those authors, physiological and behavioural testing would best be done ‘by 
the most expert and willing laboratories’, thereby establishing a kind of gold standard for phenotypes. This 
approach is best served by testing as many inbred strains as possible, including those with obvious neurological 
defects. The emphasis is placed on genetically standardized strains, and it is presumed that good measures of a 
wide range of behaviours are already available. 
 
The other approach seeks to standardize the tests on a small subset of strains or even hybrid mice lacking gross 
abnormalities in order to define the limits of normal and abnormal behaviour. This approach is most likely to 
progress rapidly if tests of known reliability and validity are employed [36,38]. For many kinds of tests, this 
may require further parametric studies with a goals of optimizing the test conditions and making it easier for 
other labs to adopt the same methods. Refinement of the tests would best be done prior to undertaking large 
scale mutagenesis screening experiments and surveys of almost all available inbred strains. 
 
While we recognize that these approaches to standardization are complementary, we are following primarily the 
second option in our present research. We believe that careful study of the psychometric and parametric aspects 
of the many available tests of mouse behaviour will enable us to identify a relatively small array of 
demonstrably good tests that are sensitive to a large portion of the total genetic variance among the more 
common inbred strains in specific behavioural domains. Such a test array would then facilitate further research 
with a wider variety of genotypes as well as investigation of important environmental effects on test 
performance. Hopefully this kind of approach to the problem of standardization will encourage other 
laboratories to adopt the same methods, but we do not believe it would be feasible or desirable to attempt to 
impose a single standard on a diverse field of research. 
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